DEVIN WATTS: Open Payments
NPI 1316627888 · NORFOLK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177 in 10 payments from 9 companies in 2025. Trend: 2023 $18 · 2024 $406 · 2025 $177
Food & beverage: $177
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: REXULTI, CAPLYTA, COBENFY, AUSTEDO XR, Kerendia, VRAYLAR, Qelbree, HETLIOZ.
Industry payments across NE — which companies pay providers there.
